Rationale for Effective Prophylaxis Against COVID‐19 Through Simultaneous Blockade of Both Endosomal and Non‐Endosomal SARS‐CoV‐2 Entry into Host Cell

• Seyed Fazel Nabavi,
• Solomon Habtemariam,
• Ioana Berindan-Neagoe,
• Cosmin Andrei Cismaru,
• Dedmer Schaafsma,
• Saeid Ghavami,
• Maciej Banach,
• Safieh Aghaabdollahian,
• Seyed Mohammad Nabavi

Affiliations

Seyed Fazel Nabavi

Applied Biotechnology Research Center Baqiyatallah University of Medical Sciences Tehran Iran

Solomon Habtemariam

Pharmacognosy Research Laboratories and Herbal Analysis Services UK University of Greenwich Kent UK

Ioana Berindan-Neagoe

Department of Functional Genomics and Experimental Pathology The Oncology Institute “Prof.Dr. Ion Chiricuta” Cluj-Napoca Romania

Cosmin Andrei Cismaru

Department of Functional Genomics and Experimental Pathology The Oncology Institute “Prof.Dr. Ion Chiricuta” Cluj-Napoca Romania

Dedmer Schaafsma

Science Impact Winnipeg Manitoba Canada

Saeid Ghavami

Department of Human Anatomy and Cell Sciences Rady Faculty of Health Sciences Max Rady College of Medicine University of Manitoba Winnipeg Manitoba Canada

Maciej Banach

Department of Hypertension Lodz, Medical University Lodz Poland

Safieh Aghaabdollahian

Department of Nanobiotechnology New Technologies Research Group Pasteur Institute of Iran Tehran Iran

Seyed Mohammad Nabavi

Applied Biotechnology Research Center Baqiyatallah University of Medical Sciences Tehran Iran